Projects

Who influences consumers’ understanding of drug risks in TV ads?

Analyzing the impact of endorsers on TV prescription drug ads

Challenge

The Food and Drug Administration’s (FDA’s) regulations about prescription drug promotion ensure that claims are truthful, accurately communicated, and offer a balanced presentation of the product’s risks and benefits. Currently, however, they do not require disclosure of an endorser’s relationship to the drug.

Marketers use “everyday people” in prescription drug advertising, anticipating consumers will

  • Identify with the individual endorsing the product
  • Perceive the endorser as credible
  • Ask doctors about the product being advertised

The FDA has tapped Westat to examine the effectiveness of using endorsers to market prescription drugs and their impact on consumers’ understanding of a prescription drug’s risks and benefits.

Solution

Working with FDA, Westat will field 2 experimental survey research studies with consumers using the selected medical conditions and analyze the results.

For this research, we are developing 2 sets of television ads for 2 different fictitious prescription drugs. For each set of ads, we will be manipulating important details, including a disclosure statement where we tell participants the spokesperson actually uses/prescribes the drug or is an actor, or we use a control where we say nothing. We are also analyzing the impact depending on whether the endorser is a patient or a physician.

We are ensuring that the creative products we develop for the study are realistic, believable, and conform to FDA guidance around direct-to-consumer (DTC) television promotion.

Our qualitative researchers will evaluate the study questionnaire and supporting materials to ensure they are working as expected with the target consumer audiences.

Results

Study results will contribute to the scientific evidence base around the effectiveness of using endorsers to promote prescription drugs to consumers. In so doing, Westat is helping FDA to ensure that prescription drug promotion is truthful, balanced, and accurately communicated.

Insights

Deep Dive with Our Experts

view all insights
  • Perspective

    Highlights of Westat at AAPOR 2024

    May 2024

    We’ve returned from the 79th Annual American Association for Public Opinion Research (AAPOR) Conference, held May 15-17 in Atlanta, where we caught up with colleagues…

  • Expert Interview

    PMGE: Blueprint for Culturally Responsive Evaluations

    May 2024

    Long known for its cutting-edge studies, the Office of Planning, Research, and Evaluation (OPRE), a department of the Administration for Children and Families (ACF), has…

  • Perspective

    Westat @ AAPOR 2024

    May 2024

    Westat experts are excited to head to Atlanta May 15-17, 2024, for the American Association for Public Opinion Research (AAPOR) 79th Annual Conference. We’re proud…

Projects

Keep Reading

view all projects

How can we help?

We welcome messages from job seekers, collaborators, and potential clients and partners.

Get in Contact

Want to work with us?

You’ll be in great company.

Explore Careers
Back to Top